{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:11:24Z","timestamp":1784862684873,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"29","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2022,7,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ankyrin repeat and fibronectin type III domain containing 1 (ANKFN1) is reported to be involved in human height and developmental abnormalities, but the expression profile and molecular function of ANKFN1 in hepatocellular carcinoma (HCC) remain unknown. This study aimed to evaluate the clinical significance and biological function of ANKFN1 in HCC and investigate whether ANKFN1 can be used for differential diagnosis in HCC. Here, we showed that ANKFN1 was upregulated in 126 tumor tissues compared with adjacent nontumorous tissues in HCC patients. The upregulation of ANKFN1 in HCC was associated with cirrhosis, alpha-fetoprotein (AFP) levels and poor prognosis. Moreover, silencing ANKFN1 expression suppressed HCC cell proliferation, migration, invasion, and metastasis in vitro and subcutaneous tumorigenesis in vivo. However, ANKFN1 overexpression promoted HCC proliferation and metastasis in an orthotopic liver transplantation model and attenuated the above biological effects in HCC cells. ANKFN1 significantly affected HCC cell proliferation by inducing G1\/S transition and cell apoptosis. Mechanistically, we demonstrated that ANKFN1 promoted cell proliferation, migration, and invasion via activation of the cyclin D1\/Cdk4\/Cdk6 pathway by stimulating the MEK1\/2-ERK1\/2 pathway. Moreover, ANKFN1-induced cell proliferation, migration, and invasion were partially reversed by ERK1\/2 inhibitors. Taken together, our results indicate that ANKFN1 promotes HCC cell proliferation and metastasis by activating the MEK1\/2-ERK1\/2 signaling pathway. Our work also suggests that ANKFN1 is a potential therapeutic target for HCC.<\/jats:p>","DOI":"10.1038\/s41388-022-02380-0","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T03:29:38Z","timestamp":1655782178000},"page":"3680-3693","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["ANKFN1 plays both protumorigenic and metastatic roles in hepatocellular carcinoma"],"prefix":"10.1038","volume":"41","author":[{"given":"Yanyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lugen","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sitang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-2195","authenticated-orcid":false,"given":"Zishu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4902-5191","authenticated-orcid":false,"given":"Fang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,21]]},"reference":[{"key":"2380_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2380_CR2","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ijc.32723","volume":"147","author":"JL Petrick","year":"2020","unstructured":"Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, et al. International trends in hepatocellular carcinoma incidence, 1978-2012. Int J Cancer. 2020;147:317\u201330.","journal-title":"Int J Cancer."},{"key":"2380_CR3","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"2380_CR4","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1002\/ijc.33130","volume":"147","author":"T Tian","year":"2020","unstructured":"Tian T, Song C, Jiang L, Dai J, Lin Y, Xu X, et al. Hepatitis B virus infection and the risk of cancer among the Chinese population. Int J Cancer. 2020;147:3075\u201384.","journal-title":"Int J Cancer"},{"key":"2380_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.hpb.2016.06.010","volume":"18","author":"I Sucandy","year":"2016","unstructured":"Sucandy I, Cheek S, Golas BJ, Tsung A, Geller DA, Marsh JW. Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors. HPB. 2016;18:756\u201363.","journal-title":"HPB"},{"key":"2380_CR6","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.canlet.2017.10.008","volume":"412","author":"J Fu","year":"2018","unstructured":"Fu J, Wang H. Precision diagnosis and treatment of liver cancer in China. Cancer Lett. 2018;412:283\u20138.","journal-title":"Cancer Lett"},{"key":"2380_CR7","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1053\/j.gastro.2017.02.040","volume":"152","author":"M Serper","year":"2017","unstructured":"Serper M, Taddei TH, Mehta R, D\u2019addeo K, Dai F, Aytaman A, et al. Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality. Gastroenterology. 2017;152:1954\u201364.","journal-title":"Gastroenterology."},{"key":"2380_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s11605-020-04555-0","volume":"25","author":"JH Kwon","year":"2021","unstructured":"Kwon JH, Song GW, Hwang S, Kim KH, Ahn CS, Moon DB, et al. Surgical outcomes of spontaneously ruptured hepatocellular carcinoma. J Gastrointest Surg. 2021;25:941\u201353.","journal-title":"J Gastrointest Surg"},{"key":"2380_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/329651a0","volume":"329","author":"KN L Breeden","year":"1987","unstructured":"L Breeden KN. Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila. Nature. 1987;329:651\u20134.","journal-title":"Nature."},{"key":"2380_CR10","doi-asserted-by":"publisher","first-page":"16029","DOI":"10.1073\/pnas.252537899","volume":"99","author":"K Leila","year":"2002","unstructured":"Leila K, Mosavi DLM Jr, Zheng-Yu Peng. Consensus-derived structural determinants of the ankyrin repeat motif. PNAS. 2002;99:16029\u201334.","journal-title":"PNAS."},{"key":"2380_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3390\/ijms22020609","volume":"22","author":"EI Kane","year":"2021","unstructured":"Kane EI, Spratt DE. Structural insights into ankyrin repeat-containing proteins and their influence in ubiquitylation. Int J Mol Sci. 2021;22:609.","journal-title":"Int J Mol Sci"},{"key":"2380_CR12","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/cells9030610","volume":"9","author":"PG Chandler","year":"2020","unstructured":"Chandler PG, Buckle AM. Development and differentiation in monobodies based on the fibronectin type 3 domain. Cells. 2020;9:610.","journal-title":"Cells."},{"key":"2380_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1110\/ps.03554604","volume":"13","author":"LK Mosavi","year":"2004","unstructured":"Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 2004;13:1435\u201348.","journal-title":"Protein Sci"},{"key":"2380_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/BF00160409","volume":"39","author":"PB Elizabeth Little","year":"1994","unstructured":"Elizabeth Little PB, Russell F. Doolittle, tracing the spread of fibronectin type III domains in bacterial glycohydrolases. J Mol Evol. 1994;39:631\u201343.","journal-title":"J Mol Evol"},{"key":"2380_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.drudis.2017.04.011","volume":"22","author":"L Ye","year":"2017","unstructured":"Ye L, Maji S, Sanghera N, Gopalasingam P, Gorbunov E, Tarasov S, et al. Structure and dynamics of the insulin receptor: implications for receptor activation and drug discovery. Drug Discov Today. 2017;22:1092\u2013102.","journal-title":"Drug Discov Today"},{"key":"2380_CR16","doi-asserted-by":"publisher","first-page":"D670","DOI":"10.1093\/nar\/gkp957","volume":"38","author":"AS Syed","year":"2010","unstructured":"Syed AS, D\u2019antonio M, Ciccarelli FD. Network of Cancer Genes: a web resource to analyze duplicability, orthology and network properties of cancer genes. Nucleic Acids Res. 2010;38:D670\u20135.","journal-title":"Nucleic Acids Res."},{"key":"2380_CR17","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.3390\/cancers13123026","volume":"13","author":"H Moon","year":"2021","unstructured":"Moon H, Ro SW. MAPK\/ERK signaling pathway in hepatocellular carcinoma. Cancers. 2021;13:3026.","journal-title":"Cancers."},{"key":"2380_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1369-1600.2010.00255.x","volume":"16","author":"A Agrawal","year":"2011","unstructured":"Agrawal A, Lynskey MT, Hinrichs A, Grucza R, Saccone SF, Krueger R, et al. A genome-wide association study of DSM-IV cannabis dependence. Addict Biol. 2011;16:514\u20138.","journal-title":"Addict Biol"},{"key":"2380_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell."},{"key":"2380_CR20","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1200\/JCO.2016.69.0032","volume":"35","author":"GKS Matthew Ingham","year":"2017","unstructured":"Matthew Ingham GKS. Cell cycle therapeutics come of Ag. J Clin Oncol. 2017;35:2949\u201359.","journal-title":"J Clin Oncol"},{"key":"2380_CR21","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/bs.acr.2020.02.002","volume":"148","author":"X Gao","year":"2020","unstructured":"Gao X, Leone GW, Wang H. Cyclin D-CDK4\/6 functions in cancer. Adv Cancer Res. 2020;148:147\u201369.","journal-title":"Adv Cancer Res"},{"key":"2380_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s13046-019-1415-5","volume":"38","author":"Y Qi","year":"2019","unstructured":"Qi Y, Wang D, Huang W, Wang B, Huang D, Xiong F, et al. CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma. J Exp Clin Cancer Res. 2019;38:413.","journal-title":"J Exp Clin Cancer Res"},{"key":"2380_CR23","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.cell.2007.12.011","volume":"131","author":"MV Semenov","year":"2007","unstructured":"Semenov MV, Habas R, Macdonald BT, He X. SnapShot: noncanonical Wnt signaling pathways. Cell. 2007;131:1378.","journal-title":"Cell."},{"key":"2380_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3803","volume":"4","author":"Z Ye","year":"2013","unstructured":"Ye Z, Zhang C, Tu T, Sun M, Liu D, Lu D, et al. Wnt5a uses CD146 as a receptor to regulate cell motility and convergent extension. Nat Commun. 2013;4:2803.","journal-title":"Nat Commun"},{"key":"2380_CR25","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.ccell.2020.03.010","volume":"37","author":"M Alvarez-Fernandez","year":"2020","unstructured":"Alvarez-Fernandez M, Malumbres M. Mechanisms of sensitivity and resistance to CDK4\/6 inhibition. Cancer Cell. 2020;37:514\u201329.","journal-title":"Cancer Cell"},{"key":"2380_CR26","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/cancers11101618","volume":"11","author":"C Braicu","year":"2019","unstructured":"Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, et al. A comprehensive review on MAPK: a promising therapeutic target in cancer. Cancers. 2019;11:1618.","journal-title":"Cancers"},{"key":"2380_CR27","doi-asserted-by":"publisher","first-page":"601929","DOI":"10.3389\/fcell.2021.601929","volume":"9","author":"S Mishra","year":"2021","unstructured":"Mishra S, Charan M, Verma AK, Ramaswamy B, Ahirwar DK, Ganju RK. Racially disparate expression of mTOR\/ERK-1\/2 allied proteins in cancer. Front Cell Dev Biol. 2021;9:601929.","journal-title":"Front Cell Dev Biol"},{"key":"2380_CR28","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1080\/21691401.2019.1584566","volume":"47","author":"M Ren","year":"2019","unstructured":"Ren M, Xu W, Xu T. Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK\/ERK signal pathway. Artif Cells Nanomed Biotechnol. 2019;47:1014\u201321.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2380_CR29","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1126\/science.7839144","volume":"267267","author":"B Derijard Jr","year":"1995","unstructured":"Derijard B Jr, Barrett T, Wu IH, Han J, Ulevitch RJ, Davis RJ. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science. 1995;267267:682\u20135.","journal-title":"Science."},{"key":"2380_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41577-020-0300-y","volume":"20","author":"G Petroni","year":"2020","unstructured":"Petroni G, Formenti SC, Chen-Kiang S, Galluzzi L. Immunomodulation by anticancer cell cycle inhibitors. Nat Rev Immunol. 2020;20:669\u201379.","journal-title":"Nat Rev Immunol"},{"key":"2380_CR31","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik L, El-Serag HB. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156:477\u201391. e1","journal-title":"Gastroenterology."},{"key":"2380_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","volume":"5","author":"ZE Stine","year":"2015","unstructured":"Stine ZE, Walton ZE, Altman BJ, Hsieh AL, Dang CV. MYC, metabolism, and cancer. Cancer Discov. 2015;5:1024\u201339.","journal-title":"Cancer Discov."},{"key":"2380_CR33","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/prot.340170405","volume":"17","author":"P Bork","year":"1993","unstructured":"Bork P. Hundreds of ankyrin-like repeats in functionally diverse proteins. Proteins. 1993;17:363\u201374.","journal-title":"Proteins."},{"key":"2380_CR34","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng.3097","volume":"46","author":"AR Wood","year":"2014","unstructured":"Wood AR, Esko T, Yang J, Vedantam S, Pers TH, Gustafsson S, et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat Genet. 2014;46:1173\u201386.","journal-title":"Nat Genet"},{"key":"2380_CR35","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/ajmg.a.37117","volume":"167A","author":"ML Martinez-Fernandez","year":"2015","unstructured":"Martinez-Fernandez ML, Fernandez-Toral J, Llano-Rivas I, Bermejo-Sanchez E, Macdonald A, Martinez-Frias ML. Delineation of the clinically recognizable 17q22 contiguous gene deletion syndrome in a patient carrying the smallest microdeletion known to date. Am J Med Genet A. 2015;167A:2034\u201341.","journal-title":"Am J Med Genet A."},{"key":"2380_CR36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ccell.2020.03.013","volume":"37","author":"M Drosten","year":"2020","unstructured":"Drosten M, Barbacid M. Targeting the MAPK Pathway in KRAS-Driven tumors. Cancer Cell. 2020;37:543\u201350.","journal-title":"Cancer Cell"},{"key":"2380_CR37","doi-asserted-by":"publisher","first-page":"119499","DOI":"10.1016\/j.lfs.2021.119499","volume":"278","author":"ER Asl","year":"2021","unstructured":"Asl ER, Amini M, Najafi S, Mansoori B, Mokhtarzadeh A, Mohammadi A, et al. Interplay between MAPK\/ERK signaling pathway and MicroRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression. Life Sci. 2021;278:119499.","journal-title":"Life Sci"},{"key":"2380_CR38","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1002\/1873-3468.12740","volume":"591","author":"EB Unal","year":"2017","unstructured":"Unal EB, Uhlitz F, Bluthgen N. A compendium of ERK targets. FEBS Lett. 2017;591:2607\u201315.","journal-title":"FEBS Lett"},{"key":"2380_CR39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21:607\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2380_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1042\/bj3090013","volume":"309","author":"RS F Schliess","year":"1995","unstructured":"F Schliess RS, H\u00e4ussinger D. Activation of extracellular signal-regulated kinases Erk-1 and Erk-2 by cell swelling in H4IIE hepatoma cells. Biochem J. 1995;309:13\u20137.","journal-title":"Biochem J."},{"key":"2380_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/md15070221","volume":"15","author":"S Tarhouni-Jabberi","year":"2017","unstructured":"Tarhouni-Jabberi S, Zakraoui O, Ioannou E, Riahi-Chebbi I, Haoues M, Roussis V, et al. Mertensene, a halogenated monoterpene, induces G2\/M cell cycle arrest and caspase dependent apoptosis of human colon adenocarcinoma HT29 Cell line through the modulation of ERK-1\/-2, AKT and NF-kappaB signaling. Mar Drugs. 2017;15:221.","journal-title":"Mar Drugs"},{"key":"2380_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71531-8","volume":"10","author":"RN Muhammad","year":"2020","unstructured":"Muhammad RN, Sallam N, El-Abhar HS. Activated ROCK\/Akt\/eNOS and ET-1\/ERK pathways in 5-fluorouracil-induced cardiotoxicity: modulation by simvastatin. Sci Rep. 2020;10:14693.","journal-title":"Sci Rep"},{"key":"2380_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","volume":"173","author":"F Sanchez-Vega","year":"2018","unstructured":"Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic signaling pathways in the cancer genome atlas. Cell. 2018;173:321\u201337.","journal-title":"Cell."},{"key":"2380_CR44","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrc3760","volume":"14","author":"M Holderfield","year":"2014","unstructured":"Holderfield M, Deuker MM, Mccormick F, Mcmahon M. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nat Rev Cancer. 2014;14:455\u201367.","journal-title":"Nat Rev Cancer"},{"key":"2380_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","volume":"81","author":"JM Kyriakis","year":"2001","unstructured":"Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81:807\u201369.","journal-title":"Physiol Rev"},{"key":"2380_CR46","doi-asserted-by":"publisher","first-page":"36179","DOI":"10.1074\/jbc.R113.515486","volume":"288","author":"X Zhou","year":"2013","unstructured":"Zhou X, Zheng Y. Cell type-specific signaling function of RhoA GTPase: lessons from mouse gene targeting. J Biol Chem. 2013;288:36179\u201388.","journal-title":"J Biol Chem"},{"key":"2380_CR47","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.3390\/cells10071831","volume":"10","author":"N Mosaddeghzadeh","year":"2021","unstructured":"Mosaddeghzadeh N, Ahmadian MR. The RHO family GTPases: mechanisms of regulation and signaling. Cells. 2021;10:1831.","journal-title":"Cells."},{"key":"2380_CR48","doi-asserted-by":"publisher","first-page":"173815","DOI":"10.1016\/j.ejphar.2020.173815","volume":"894","author":"M Iyer","year":"2021","unstructured":"Iyer M, Subramaniam MD, Venkatesan D, Cho SG, Ryding M, Meyer M, et al. Role of RhoA-ROCK signaling in Parkinson\u2019s disease. Eur J Pharmacol. 2021;894:173815.","journal-title":"Eur J Pharmacol"},{"key":"2380_CR49","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s11011-021-00709-4","volume":"36","author":"W Lu","year":"2021","unstructured":"Lu W, Chen Z, Wen J. RhoA\/ROCK signaling pathway and astrocytes in ischemic stroke. Metab Brain Dis. 2021;36:1101\u20138.","journal-title":"Metab Brain Dis"},{"key":"2380_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1350-6","volume":"10","author":"Y Sun","year":"2019","unstructured":"Sun Y, Zhang D, Guo X, Li W, Li C, Luo J, et al. MKK3 modulates JNK-dependent cell migration and invasion. Cell Death Dis. 2019;10:149.","journal-title":"Cell Death Dis"},{"key":"2380_CR51","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/14756366.2020.1720013","volume":"35","author":"Q Wu","year":"2020","unstructured":"Wu Q, Wu W, Jacevic V, Franca TCC, Wang X, Kuca K. Selective inhibitors for JNK signalling: a potential targeted therapy in cancer. J Enzym Inhib Med Chem. 2020;35:574\u201383.","journal-title":"J Enzym Inhib Med Chem"},{"key":"2380_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-018-0397-9","volume":"11","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang Y, Zhang Z. Adipokine RBP4 drives ovarian cancer cell migration. J Ovarian Res. 2018;11:29.","journal-title":"J Ovarian Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02380-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02380-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T10:07:44Z","timestamp":1657879664000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-022-02380-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":52,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2022,7,15]]}},"alternative-id":["2380"],"URL":"https:\/\/doi.org\/10.1038\/s41388-022-02380-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"19 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}